Ahhhh, I see it now.
I am time constrained, appreciate your thoughtful responses. Thought I might have imagined or mistakenly attributed another biotech on the point of European trials. But I did get that right: July 29 news. Here is the thing.... As I said, I have been a salesman and later a sales manager of scientific instruments for 15 years (that was 30 years ago but times haven't changed much.
American and Canadian approvals don't differ too much. We use the same electricity and basically follow similar practices for labour. Europe marches to a different drum. The use 220v not 110v and have different electric codes. I would imagine their safety codes are different as well, certainly their drug approvals are different than ours in north America. Some are more stringent some are less so.
This has always been a difficulty in adopting European instrumentation in Canada and the USA. For a company like Siemens for example .... the largest instrumentation process control company in the world... all of their equipment has Canadian and American approvals because the European approvals just did not stand up to our requirements here.... and vica versa. I represented Siemens competition for a short time in Canada, Hartman &Braun, and I had no end of difficulty when they did not have our approvals.
So, for Shirazi to say TLT is dropping going to Europe for now. I frankly applaud that obvious decision. Why? For 2 reasons:
1. He probably would have to meet different criteria to get a European approval
2. He does not have the qualified people to run a European operation.
That does not mean that Europe is forgotten. Do you think that Europe will ignore the success of the TLT's cure for bladder cancer if we get the results that we are all hoping for??? Nopes, they will be clamouring for our procedure.
Success in the Canada/USA means everything and they should be focusing their efforts in North America first.
Instead of being ho-hum about TLT's decision to let Europe slide for now....we should be happy about it. It would have spread TLT's resources too thin IMHO.
After all, we don't want a repeat of that blunder of the devices group just because poorly qualified people are running with the ball....right!